Luminescent Pt II and Pt IV Platinacycles with Anticancer Activity Against Multiplatinum‐Resistant Metastatic CRC and CRPC Cell Models-Reference-Cited by-同舟云学术

Luminescent Pt II and Pt IV Platinacycles with Anticancer Activity Against Multiplatinum‐Resistant Metastatic CRC and CRPC Cell Models

Published:2020-01-30 Issue:9 Volume:26 Page:1947-1952
ISSN:0947-6539
Container-title:Chemistry – A European Journal
language:en
Short-container-title:Chem. Eur. J.

Author:

Lázaro Ariadna¹^ORCID,Balcells Cristina²^ORCID,Quirante Josefina³⁴^ORCID,Badia Josefa⁵⁴^ORCID,Baldomà Laura⁵⁴^ORCID,Ward Jas S.⁶^ORCID,Rissanen Kari⁶^ORCID,Font‐Bardia Mercè⁷^ORCID,Rodríguez Laura¹⁸^ORCID,Crespo Margarita¹⁴^ORCID,Cascante Marta²⁴⁹^ORCID

Affiliation:

1. Dpt de Química Inorgànica i Orgànica, Secció de Química Inorgànica Facultat de Química Universitat de Barcelona Martí i Franquès 1–11 08028 Barcelona Spain

2. Dpt. of Biochemistry and Molecular Biomedicine Faculty of Biology Universitat de Barcelona Av. Diagonal, 643 08028 Barcelona Spain

3. Laboratori de Química Orgànica, Facultat de Farmàcia Universitat de Barcelona Av. Joan XXIII, 27–31 08028 Barcelona Spain

4. Institut de Biomedicina Universitat de Barcelona (IBUB) 08028 Barcelona Spain

5. Dpt de Bioquímica i Fisiologia, Facultat de Farmàcia Universitat de Barcelona Av. Joan XXIII, 27–31 08028 Barcelona Spain

6. Dpt of Chemistry, Nanoscience Center University of Jyvaskyla P.O. Box 35 Jyvaskyla 40014 Finland

7. Unitat de difracció de RX, CCiTUB Universitat de Barcelona Solé i Sabarís 1–3 08028 Barcelona Spain

8. Institut de Nanociència i Nanotecnologia, Universitat de Barcelona (IN2UB) 08028 Barcelona Spain

9. Centro de Investigación Biomédica en Red de Enfermedades Hepáticasydigestivas, (CIBEREHD) Instituto de Salud Carlos III (ISCIII) Madrid Spain

Funder

Ministerio de Economía y Competitividad

Instituto de Salud Carlos III

Publisher

Wiley

Subject

General Chemistry,Catalysis,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/chem.201905325

Reference35 articles.

1. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

2. Platinum(IV) Prodrugs – A Step Closer to Ehrlich's Vision?

3. Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment

4. Multi-action Pt(IV) anticancer agents; do we understand how they work?

5. Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the effect of the axial ligands on the anticancer activity of [C,N,N′] Pt(iv) cyclometallated compounds;Dalton Transactions;2024

2. Visible light harvesting alkyne hydrosilylation mediated by pincer platinum complexes;Journal of Catalysis;2023-12

3. Disparities in Cisplatin-Induced Cytotoxicity—A Meta-Analysis of Selected Cancer Cell Lines;Molecules;2023-07-30

4. Toward Near-Infrared Emission in Pt(II)-Cyclometallated Compounds: From Excimers’ Formation to Aggregation-Induced Emission;Inorganic Chemistry;2023-01-25

5. A new family of luminescent [Pt(pbt)₂(C₆F₅)L]ⁿ⁺ (n = 1, 0) complexes: synthesis, optical and cytotoxic studies;Dalton Transactions;2023